FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← VRDN · Viridian Therapeutics, Inc.DE
424B5The Raise

Viridian Therapeutics, Inc.DE files 424B5

Filed Mar 4, 2025 · 1y ago · Accession 0001193125-25-044400

Plain English

424B5 filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Viridian Therapeutics, Inc.DE
Ticker
VRDN
CIK
1590750
Form type
424B5
Filing date
Mar 4, 2025
Report date
—
Document
d126976d424b5.htm
Size
504 KB

More from VRDN

8-KReg FD Disclosure · Company UpdateJun 29, 20268-KShareholder VoteJun 3, 20268-KAgreement TerminatedMay 28, 20268-KMaterial AgreementMay 26, 2026SC 13D/AThe StakesMay 13, 20268-KMaterial Agreement · New Debt / ObligationMay 11, 2026